Related Experiment Video
Updated: Apr 8, 2026

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
Published on: May 20, 2024
Inflammatory Signatures and Biomarkers: The Renal-Vesical Axis in Alzheimer Progression
Yebeen Kim1, Jaewoon Jung1, Asifiwe Clarisse Cirunduzi1
1Department of Medical Biotechnology, College of Life Science and Biotechnology, Dongguk University, Seoul, Korea.
None:
Alzheimer disease (AD) has long been viewed as a disorder confined to the central nervous system. Accumulating evidence, however, indicates that systemic inflammation and peripheral organ dysfunction are closely linked to disease progression. Notably, the bladder and kidney have emerged as peripheral organs that respond sensitively to neuroinflammation and systemic inflammatory signaling. In this review, we synthesize current evidence supporting a bladder-kidney-brain axis in AD, with emphasis on inflammatory pathways that connect central neurodegeneration with peripheral organ responses. We categorize biomarkers reflecting functional alterations, cellular stress responses, and tissue injury in the bladder and kidney, highlighting mediators reported in both organs. Importantly, many of these biomarkers are measurable in serum and urine, offering accessible peripheral readouts of AD-associated systemic pathology. This integrated framework underscores the biological relevance of urological organs in AD progression and provides a conceptual basis for identifying peripheral signatures associated with early disease-related changes.
More Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment

